• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The future direction of post-transcatheter aortic valve replacement reinterventions: insights from the Transcatheter Valve Therapy Registry.经导管主动脉瓣置换术后再干预的未来方向：来自经导管瓣膜治疗注册研究的见解
Ann Cardiothorac Surg. 2025 Mar 31;14(2):154-156. doi: 10.21037/acs-2025-etavr-0019. Epub 2025 Mar 27.
2
Surgical Explantation of Transcatheter Aortic Valve Bioprostheses: A Statewide Experience.经导管主动脉瓣生物瓣假体的外科取出术：全州范围的经验。
Circ Cardiovasc Interv. 2021 Apr;14(4):e009927. doi: 10.1161/CIRCINTERVENTIONS.120.009927. Epub 2021 Mar 15.
3
Explant vs Redo-TAVR After Transcatheter Valve Failure: Mid-Term Outcomes From the EXPLANTORREDO-TAVR International Registry.经导管瓣膜失效后取出瓣膜与再次经导管主动脉瓣置换术：EXPLANTORREDO-TAVR国际注册研究的中期结果
JACC Cardiovasc Interv. 2023 Apr 24;16(8):927-941. doi: 10.1016/j.jcin.2023.01.376.
4
The current state of transcatheter aortic valve replacement explant: an updated systematic review.经导管主动脉瓣置换术取出物的当前状态：一项更新的系统评价
Ann Cardiothorac Surg. 2025 Mar 31;14(2):85-97. doi: 10.21037/acs-2024-etavr-0075. Epub 2024 Oct 11.
5
Aortic valve versus root surgery after failed transcatheter aortic valve replacement.经导管主动脉瓣置换失败后的主动脉瓣与根部手术对比
J Thorac Cardiovasc Surg. 2023 Nov;166(5):1418-1430.e4. doi: 10.1016/j.jtcvs.2021.12.060. Epub 2022 Mar 26.
6
Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis.经导管主动脉瓣置换术或外科主动脉瓣置换术治疗重度主动脉瓣狭窄后的再次介入治疗。
JACC Cardiovasc Interv. 2024 Apr 22;17(8):1007-1016. doi: 10.1016/j.jcin.2024.01.292. Epub 2024 Apr 3.
7
The current state of redo transcatheter aortic valve replacement (TAVR) and limitations: why TAVR explant is important as the valve reintervention strategy.再次经导管主动脉瓣置换术（TAVR）的现状及局限性：为何TAVR瓣膜取出作为瓣膜再次干预策略很重要。
Ann Cardiothorac Surg. 2025 Mar 31;14(2):98-111. doi: 10.21037/acs-2024-etavr-0149. Epub 2025 Mar 4.
8
Impact of transcatheter heart valve type on outcomes of surgical explantation after failed transcatheter aortic valve replacement: the EXPLANT-TAVR international registry.经导管主动脉瓣置换术后失败行外科瓣置换术时不同经导管心脏瓣膜类型对结局的影响：EXPLANT-TAVR 国际注册研究。
EuroIntervention. 2024 Jan 15;20(2):e146-e157. doi: 10.4244/EIJ-D-23-00722.
9
Redo transcatheter aortic valve replacement in degenerated transcatheter bioprosthesis (TAV-in-TAV).再次行经导管主动脉瓣置换术治疗退行性经导管生物瓣（TAV-in-TAV）。
Expert Rev Cardiovasc Ther. 2023 Jul-Dec;21(10):703-712. doi: 10.1080/14779072.2023.2266368. Epub 2023 Oct 26.
10
Exploring the Difference in Post-procedural Stroke Rates Between Patients with Aortic Stenosis Who Undergo Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement.探索接受经导管主动脉瓣置换术与外科主动脉瓣置换术的主动脉瓣狭窄患者术后中风发生率的差异。
Cureus. 2018 Apr 17;10(4):e2494. doi: 10.7759/cureus.2494.

本文引用的文献

1
Trends in Transcatheter Aortic Valve Replacement Outcomes: Insights From the STS/ACC TVT Registry.经导管主动脉瓣置换术的结局趋势：来自美国胸外科医师协会/美国心脏病学会经导管瓣膜治疗注册研究的见解
JAMA Cardiol. 2024 Dec 1;9(12):1115-1123. doi: 10.1001/jamacardio.2024.3453.
2
Guidelines vs Practice: Surgical Versus Transcatheter Aortic Valve Replacement in Adults ≤60 Years.指南与实践：60岁及以下成人的外科主动脉瓣置换术与经导管主动脉瓣置换术对比
Ann Thorac Surg. 2025 Apr;119(4):861-869. doi: 10.1016/j.athoracsur.2024.07.036. Epub 2024 Aug 22.
3
Cardiac Surgery After Transcatheter Aortic Valve Replacement: Trends and Outcomes.经导管主动脉瓣置换术后的心脏手术：趋势与结果。
Ann Thorac Surg. 2024 Jul;118(1):155-162. doi: 10.1016/j.athoracsur.2024.03.024. Epub 2024 Apr 3.
4
Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study.重复经导管主动脉瓣置换术使用球囊扩张瓣的结果：注册研究。
Lancet. 2023 Oct 28;402(10412):1529-1540. doi: 10.1016/S0140-6736(23)01636-7. Epub 2023 Aug 31.
5
Redo-TAVR: Essential Concepts, Updated Data and Current Gaps in Evidence.再次经导管主动脉瓣置换术：基本概念、最新数据及当前证据空白
J Clin Med. 2023 Jul 20;12(14):4788. doi: 10.3390/jcm12144788.
6
Explant vs Redo-TAVR After Transcatheter Valve Failure: Mid-Term Outcomes From the EXPLANTORREDO-TAVR International Registry.经导管瓣膜失效后取出瓣膜与再次经导管主动脉瓣置换术：EXPLANTORREDO-TAVR国际注册研究的中期结果
JACC Cardiovasc Interv. 2023 Apr 24;16(8):927-941. doi: 10.1016/j.jcin.2023.01.376.
7
Redo-transcatheter aortic valve replacement with the supra-annular, self-expandable Evolut platform: Insights from the Transcatheter valve Therapy Registry.再次行经导管主动脉瓣置换术，使用 supra-annular、自扩张 Evolut 平台：来自经导管瓣膜治疗注册研究的见解。
Catheter Cardiovasc Interv. 2022 Feb;99(3):869-876. doi: 10.1002/ccd.29941. Epub 2021 Sep 17.
8
STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术的STS-ACC TVT注册研究
J Am Coll Cardiol. 2020 Nov 24;76(21):2492-2516. doi: 10.1016/j.jacc.2020.09.595.
9
Surgical explantation of transcatheter aortic bioprostheses: Results and clinical implications.经导管主动脉生物瓣的外科取出：结果和临床意义。
J Thorac Cardiovasc Surg. 2021 Aug;162(2):539-547.e1. doi: 10.1016/j.jtcvs.2019.11.139. Epub 2020 Jan 12.
10
Prosthesis-Patient Mismatch in Patients Undergoing Transcatheter Aortic Valve Replacement: From the STS/ACC TVT Registry.经导管主动脉瓣置换术患者的假体-患者不匹配：来自 STS/ACC TVT 注册研究。
J Am Coll Cardiol. 2018 Dec 4;72(22):2701-2711. doi: 10.1016/j.jacc.2018.09.001. Epub 2018 Sep 23.

The future direction of post-transcatheter aortic valve replacement reinterventions: insights from the Transcatheter Valve Therapy Registry.

作者信息

Percy Edward, Bavaria Joseph E

机构信息

Division of Cardiovascular Surgery, University of British Columbia, Vancouver, BC, Canada.

Division of Cardiovascular Surgery, Thomas Jefferson University Hospitals, Philadelphia, PA, USA.

出版信息

Ann Cardiothorac Surg. 2025 Mar 31;14(2):154-156. doi: 10.21037/acs-2025-etavr-0019. Epub 2025 Mar 27.

DOI:10.21037/acs-2025-etavr-0019
PMID:40270853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12013769/
Abstract
摘要